Bruce Colwell

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 952 citations · Full text

Medicine, Oncology, Pharmacology +13

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

John R. Mackey, Miguel Martín, Tadeusz Pieńkowski et al. · The Lancet Oncology · 2012 · 223 citations

Medicine, Oncology, Pharmacology +15

Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study

Akihito Kawazoe, Rui‐Hua Xu, Pilar García‐Alfonso et al. · Journal of Clinical Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

Arjun Gupta, Christopher J. O’Callaghan, Liting Zhu et al. · JCO Oncology Practice · 2023 · 69 citations · Full text

Medicine, Oncology, Pharmacology +15

Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer

Eric X. Chen, Jonathan M. Loree, Emma Titmuss et al. · JAMA Network Open · 2023 · 64 citations · Full text

Medicine, Immunology, Oncology +17